Cart
sales@molnova.com
Saikosaponin S
CAS No. 219690-93-4
Saikosaponin S( ——— )
Catalog No. M38128 CAS No. 219690-93-4
Saikosaponin S is a natural product that can be isolated from Bupleurum scorzonerifolium.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSaikosaponin S
-
NoteResearch use only, not for human use.
-
Brief DescriptionSaikosaponin S is a natural product that can be isolated from Bupleurum scorzonerifolium.
-
DescriptionSaikosaponin S is a natural product that can be isolated from Bupleurum scorzonerifolium.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number219690-93-4
-
Formula Weight943.12
-
Molecular FormulaC48H78O18
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jia A, et al. Saikosaponins: A Review of Structures and Pharmacological Activities. Natural Product Communications, 2022, 17(5): 1934578X221094908.
molnova catalog
related products
-
CB-839
CB-839 (Telaglenastat) is a potent, selective, and orally bioavailable inhibitor of glutaminase with IC50 of 28 and 23 nM for glutaminase in kidney and brain (GAC and KGA).
-
Emicizumab
Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
-
Cecropin A
Cecropin A is a naturally occurring, linear, cationic, 37-residue antimicrobial peptide.
